Drag a card by its title · ⚙ to size, swap or remove

The company

MiNK Therapeutics, Inc.

INKT · Nasdaq

Health CareBiotechnologyNot moving yet

INKT stood above a rising 150-day average in 6 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 16.9% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 2
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $167K
Officials’ trades on record: 0
Institutions holding: 27 (+6)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 6 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months6

Buyers · sellers0 · 2

Who	Did	Shares	Traded
Jennifer BuellChief Executive Officer	sold	6,938at $10.56	12 Oct 2026filed 14 Oct 2026
Barbara RyanDirector	sold	500at $12.68	4 Jun 2026filed 5 Jun 2026
Barbara RyanDirector	sold	1,000at $12.80	4 Jun 2026filed 5 Jun 2026
Barbara RyanDirector	sold	300at $15.28	10 Mar 2026filed 11 Mar 2026
Barbara RyanDirector	sold	500at $15.57	10 Mar 2026filed 11 Mar 2026
Barbara RyanDirector	sold	500at $15.30	10 Mar 2026filed 11 Mar 2026
Barbara RyanDirector	sold	200at $10.17	9 Mar 2026filed 11 Mar 2026
Barbara RyanDirector	sold	100at $10.83	2 Mar 2026filed 4 Mar 2026
Barbara RyanDirector	sold	400at $10.86	27 Feb 2026filed 4 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders27+6 on the quarter

New · exited9 · 3

Reported value$2.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	68,660$803K	+9,296+15.7%
DNB Asset Management ASnew · filed 11 Aug 2026	55,142$645K	+55,142
Longbow Finance SAunchanged · filed 29 Jul 2026	16,667$195K	00.0%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026	15,573$182K	-1,772−10.2%
CITADEL ADVISORS LLCnew · filed 14 Aug 2026	15,440$180K	+15,440
BlackRock, Inc.added · filed 7 Aug 2026	13,382$156K	+7,179+115.7%
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026	8,287$97K	00.0%
UBS Group AGreduced · filed 13 Aug 2026	4,885$57K	-10,317−67.9%
Steward Partners Investment Advisory, LLCunchanged · filed 13 Aug 2026	2,000$23K	00.0%
US BANCORP \DE\new · filed 12 Aug 2026	1,995$23K	+1,995